Skip to content

Risk factor analysis for nausea and vomite induceded by narcotic drugs, multi center trial.

Risk factor analysis for nausea and vomite induceded by narcotic drugs, multi center trial. - Risk factor analysis for nausea and vomite induceded by narcotic drugs, multi center trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008450
Enrollment
400
Registered
2012-07-17
Start date
2012-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

None listed

Sponsors

Hanshin Palliative Pharmacotherapy Network
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All malignant disease patients who have no further history of Narcotic drugs administration. Histopathology stage : no restriction Agreement document : required

Exclusion criteria

Exclusion criteria: Narcotic drugs only single administration. (Not routine use.) Withdrawal administration except a reason of nausea/vomit. History of Codeine phosphate , Tramadol Hydrochloride, Pentazocine, Buprenorphine administration.

Design outcomes

Primary

MeasureTime frame
We analyze correlation between Patient background factor and nausea/vomit incidence for 7days after narcotic drugs administration.

Countries

Japan

Contacts

Public ContactHiroshi Ueda

Itami City Hospital Pharmacy

ueda-itm@umin.ac.jp0727773773

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026